- People
- Offices
- Capabilities
back- Capabilities
- Corporate, Finance and Investments
- back
- Corporate, Finance and Investments
- Overview
- Activist Defense
- Banking and Institutional Finance
- Capital Markets
- Construction and Procurement
- Corporate Governance
- Emerging Companies and Venture Capital
- Employee Benefits and Executive Compensation
- Energy and Infrastructure Projects
- Financial Restructuring
- Global Human Capital and Compliance
- Investment Funds and Asset Management
- Mergers and Acquisitions (M&A)
- Middle East and Islamic Finance and Investment
- Private Credit & Special Situations
- Private Equity
- Public Companies
- Immobilier
- Structured Finance and Securitization
- Tax
- Technology Transactions
- Government Matters
- back
- Government Matters
- Overview
- Antitrust
- Data, Privacy and Security
- Environmental, Health and Safety
- FDA and Life Sciences
- Government Advocacy and Public Policy
- Government Contracts
- Healthcare
- International Trade
- National Security and Corporate Espionage
- Securities Enforcement and Regulation
- Special Matters and Government Investigations
- Trial and Global Disputes
- back
- Trial and Global Disputes
- Overview
- Appellate, Constitutional and Administrative Law
- Bankruptcy and Insolvency Litigation
- Class Action Defense
- Commercial Litigation
- Construction and Engineering Disputes
- Corporate and Securities Litigation
- E-Discovery
- Intellectual Property
- International Arbitration and Litigation
- Labor and Employment
- Product Liability
- Professional Liability
- Toxic & Environmental Torts
- Industries / Issues
- back
- Industries / Issues
- Automotive, Transportation and Mobility
- Energy
- Financial Services
- Food and Beverage
- Higher Education
- Life Sciences and Healthcare
- Technology
- #MeToo
- Buy American
- COVID-19 Vaccine Rollout
- Crisis Management
- Environmental Agenda
- Environmental, Social and Governance (ESG)
- Focus on Women's Health
- Russia/Ukraine
- Special Purpose Acquisition Companies (SPACs)
- Careers
- News & Insights
- About
- Languages
Events 234 results
Webinar
juillet 27, 2022
The CMS SAFER Self-Assessment Attestation: New Requirements and New Opportunities for Patient Safety
Webinar
juillet 13, 2022
The Legal Life Cycle of Fleet Electrification
Webinar
juin 29, 2022
Food & Beverage: 2022 Mid-Year Transactional Review with King & Spalding and Goldman Sachs
Webinar
juin 22, 2022
Navigating the Privacy and Security Landscape: Recent Developments and Best Practices for Life Sciences Companies
Webinar
juin 21, 2022
Telemedicine 2.0: What Providers Need to Know as They Design Their Post-Pandemic Telemedicine Strategies
Webinar
juin 16, 2022
Let's Talk Tech: Understanding Non-Fungible Tokens (NFTs)
Webinar
mai 24, 2022
Pre-empting and Navigating Joint Venture and Shareholder Disputes: An Indonesian Perspective
Webinar
mai 18, 2022
Trending Now: Privacy and Cybersecurity Regulations
Webinar
mai 17, 2022
How PFAS Legal Issues Impact Companies in Real Life: Representative Case Studies
Webinar
avril 20, 2022
Regulation of Cell and Gene Therapies: An Overview
Webinar
avril 6, 2022
Data Governance in Healthcare